# Gameto: Research, New York, United States

> Gameto: Gameto is a biotechnology company founded in 2020, dedicated to advancing women’s reproductive health. Based in New York, United States. Founded 2020.

Source: https://millionrounds.com/startup/gameto (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Gameto

Gameto is a biotechnology company founded in 2020, dedicated to advancing women’s reproductive health.

Funding reported Last round: Series B

Research New York, United States

Company summary

- **Founded:** 2020 6 years old
- **Team:** 58 51 to 200 people
- **Funding reported:** $73M in dollars
- **Last round:** Series B May 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Gameto has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Gameto

Gameto is a biotechnology company founded in 2020, dedicated to advancing women’s reproductive health.

Based in New York and Austin, Gameto focuses on addressing unmet needs for women and families throughout their reproductive years. The company employs cell engineering and in vitro biology to develop therapeutics aimed at improving fertility care. One of Gameto's key programs is Fertilo, designed for IVF and egg freezing, which seeks to make the treatment process shorter, safer, and less reliant on hormonal injections. The company also has a broader pipeline that includes Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic targeting health issues related to primary ovarian insufficiency and menopause. Gameto is committed to redefining women’s health and fertility care through innovative therapeutics.

## What company datasets say Gameto raised

Funding, as reported

Reported in all **$73M** in dollars

Rounds **5**

Last round **Series B**

Last round size **$44M**

Last round date **May 2024**

Investors listed **26**

SEC Form D **$144M sold, 5 filings, last Aug 2025**

## Founders and team

From Gameto's own website: 1 founder, 10 on the team.

**Dina Turner** Co-founder & Chief Executive Officer

- **Agustina Imfeld** Counsel & Chief Legal Officer
- **Christian Kramme** Chief Scientific Officer
- **Gus Haddad** Chief Medical Officer
- **Bruna Paulsen** VP of Manufacturing & Therapeutic Development
- **Sofia Steinberger** VP of Finance & Strategic Operations
- **Emily Bosworth Cassidy** Director of Business Development & Corporate Strategy
- **Jonathan Hostens** Director
- **Kristina Simmons** Director
- **Maryanna Saenko** Director
- **Sabrina Piechota** Embryology Department Manager

## On 10 portfolio pages

Investors who name them

- [For Good Ventures](https://millionrounds.com/fund/for-good-ventures)
- [Future Ventures](https://millionrounds.com/fund/future-ventures)
- [Portfolia](https://millionrounds.com/fund/portfolia)
- [Jazzya Investments](https://millionrounds.com/fund/jazzya-investments)
- [Korify Capital](https://millionrounds.com/fund/korify-capital)
- [Myelin VC](https://millionrounds.com/fund/myelin-vc)
- [Overwater Ventures](https://millionrounds.com/fund/overwater-ventures)
- [Ingeborg Investments](https://millionrounds.com/fund/ingeborg-investments)
- [Solari Capital](https://millionrounds.com/fund/solari-capital)
- [Peter H. Diamandis (PHD Ventures)](https://millionrounds.com/fund/peter-h-diamandis-phd-ventures)

Each firm lists Gameto on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care embryology embryo development clinical protocols women's health stem cell ovarian support ovarian support cell therapy biotech therapeutics biotechnology research research publications infertility solutions manufacturing fertilo ovarian disease cell therapy cell engineering

Built with from their website

Dynamic Conditions WordPress.org IQMS Microsoft PowerPoint Flow Font Awesome Elementor YouTube Spotify Google Workspace

+8 more

Gem Viewport Meta Mimecast Hubspot Varnish All in One SEO Hello Elementor Apple Business Manager

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 8731
- **Region:** New York
- **Revenue:** $1.0M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/gameto)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Gameto in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)